Methods | Randomised controlled trial | |
Participants | Bipolar disorder and schizoaffective disorder | |
Interventions | 4 on oxcarbazepine, 6 on lithium | |
Outcomes | Relapse of disorder | |
Notes | 36 month study . Text documented 15 patients being initally randomised. Rest of five patients not accounted for. All patients on oxcarbazepine dropped out, however no mention of handling of drop outs in final analysis. No subgroup analysis possible as patients having schizoaffective disorder not delineated. All patients discontinued therapy before two years itself, reason for discontinuation for individual patients not described. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | High risk | C ‐ Inadequate |